| |
|
|
|
Adma Biologics  
|
|
3.42 0.05 (0.01%) |
08-05 12:13 |
|
Open: |
3.47 |
Pre close: |
3.37 |
Target:
|
4.24
|
|
High: |
3.49 |
Low: |
3.32 |
Resistance:
|
3.63
4.20
|
|
Volume: |
2,263,384 |
Market Cap: |
295M |
Support:
|
2.71
2.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.49
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
3.09 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
2.88 |
Stochastic Oscillator |
%K(14,3):
|
43.19  |
|
MA(250): |
3.66 |
%D(3): |
49.55 |
|
Average Volume(K) |
3-Month: |
389890
|
52-Week |
High:
|
5.48 |
|
10-Days: |
951024 |
Low: |
1.45 |
|
RSI |
RSI(14):
|
58.22 |
Change(%): |
-2.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.890 |
Return on Equity (ttm) |
-102.4 |
Shares Out. (M) |
86.35 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-19.5 |
Shares Float (M) |
67.92 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.35 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
189.1 |
% Held by Institutions |
47.91 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
-0.118 |
Shares Short (K) |
9560 |
|
Book Value (p.s.) |
1.120 |
EBITDA (p.s.) |
-0.483 |
P/E |
-3.79 |
|
Sales Per Share |
0.417 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.01 |
|
Profit Margin |
-151.18 |
Operating Cash Flow
(M) |
-86.55 |
P/S |
8.09 |
|
Operating Margin |
-124.89 |
Levered Free Cash Flow
(M) |
-69.82 |
P/CF |
-3.37 |
|
|
|
|
|
|
